Laxatab

Quick links to important sections

Laxatab

Method of action: Laxative

Treatment option: Constipation, Proctitis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Laxatab

Quick Facts

Property Description
Active ingredient Sodium Picosulfate (INN)
Form Tablet or Oral solution
Pharmacological class Stimulant Laxative / Contact Laxative
General purpose Bowel movement facilitation / Relief of constipation
Origin Synthetic chemical entity

What Type of Medicine is Laxatab?

Laxatab is defined as a specific pharmaceutical agent whose active substance is Sodium Picosulfate, which is clinically recognized as a Stimulant Laxative. This compound is classified under the Gastrointestinal Agents category. Sodium Picosulfate is a Contact Laxative. This classification means the medicine is designed to interact directly with the colonic lining, providing a reliable and different mechanism compared to osmotic agents. The core therapeutic purpose of this drug is to serve as a purgative for effective and predictable bowel movement facilitation, often utilized in scenarios requiring prompt relief from symptoms of constipation.

Is Laxatab a Synthetic Compound and What are its Forms?

The core component, Sodium Picosulfate, is an entirely synthetic compound, belonging to the chemical family of Diphenylmethane Derivatives. The medication is designed for the oral route of administration and is typically found in the dosage forms of a tablet or an oral solution (liquid drops). Its identity is defined by its function as a biologically inactive prodrug, a key feature distinguishing it from other direct-acting laxatives; it ensures the drug remains inert until it reaches the specific environment of the large intestine. While available as a Single product, Sodium Picosulfate is also frequently combined with osmotic agents in specific preparations, known as a Combination product, a feature often targeting comprehensive bowel cleansing procedures.

What is the General Purpose of Laxatab?

The general purpose of this medicine is to reliably resolve symptoms of constipation by inducing a comprehensive and controlled evacuation of the large bowel. The drug achieves its goal by augmenting peristalsis, the natural wave-like muscular contractions of the colon. This targeted stimulation leads to a powerful purgative effect necessary for thorough elimination. This reliable mechanism ensures the required propulsion and elimination of retained stool without causing generalized systemic effects, focusing its action solely within the gastrointestinal tract.

What side effects are possible with Laxatab?

Possible Side Effects and Safety Information

The safety profile of Laxatab, a stimulant laxative, is primarily defined by gastrointestinal and general systemic adverse reactions, alongside specific warnings for high-risk populations.

Adverse Reactions

The most commonly documented side effects are typically related to the gastrointestinal system. These include:

  • Gastrointestinal Disorders: Abdominal discomfort, diarrhea, abdominal cramp, and abdominal pain.
  • Systemic Effects: Dizziness and increased magnesium levels in the blood (hypermagnesemia) are also reported.

Serious Safety Considerations

Official safety advice highlights several restrictions and serious risks:

  • Pregnancy: Laxatab is classified as highly unsafe during pregnancy due to the potential for serious harm to the unborn baby, including birth defects and pregnancy loss. Its use is contraindicated for pregnant patients.
  • Kidney Function: Caution is advised for patients with existing kidney disease, as the medication may increase the risk of kidney problems, potentially requiring dose adjustment. Symptoms of this risk include decreased urination, edema, and lower back pain.
  • Duration Restriction: Use of Laxatab is restricted to short-term periods (generally not exceeding one week) as prolonged use may lead to dependency on the laxative action for bowel function.
  • Drug Interference: The medication may interfere with the absorption of other orally administered medicines, necessitating a separation of administration times, typically two hours.

Population-Specific Warnings

Safety notes also advise particular caution for:

  • Pediatric Use: Generally not recommended for children under 12 years of age without explicit medical advice.
  • Breastfeeding: Use should only occur if the expected maternal benefit is determined to outweigh the potential risk to the infant, as the drug may pass into breastmilk.

Note: Contraindications based on regulatory documents typically include conditions such as bowel blockage, intestinal obstruction, and bowel inflammation.

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the officially documented manifestations and required actions in the event of an overdose of medicines containing Sodium Picosulfate, based strictly on government regulatory sources.


Documented Overdose Manifestations

Official regulatory sources document that the principal manifestations of overdose are related to its severe laxative effect, resulting in significant metabolic disturbance.

Type of Overdose Key Manifestations (Regulatory-Documented)
Acute High-Dose Severe Diarrhoea and Abdominal Cramps, leading to Fluid and Electrolyte Imbalance (e.g., Hypokalaemia).
Chronic Overdosage Chronic Abdominal Pain, Renal Calculi, Renal Tubular Damage, Secondary Hyperaldosteronism, and Metabolic Alkalosis.

Chronic abuse or ingestion of excessive doses is also associated with Colonic mucosal ischaemia and Muscle Weakness secondary to low potassium levels.


Official Emergency Actions Required

If you take more of this medicine than you should, you must talk to a doctor or go to a hospital straight away. Treatment is primarily supportive, focused on correcting the major imbalances caused by fluid loss.

Management Focus Regulator-Documented Action
Immediate Action Inducing Vomiting or Gastric Lavage may be considered shortly after ingestion.
Supportive Care Replacement of fluids and Correction of electrolyte imbalance. Administration of antispasmodics may be used.

There is no specific antidote documented in the official regulatory labeling for sodium picosulfate overdose. Fluid and electrolyte replacement is especially important in the elderly and the young.

Therapeutic Uses of Laxatab

What Laxatab Treats: Main Uses and Benefits

The core purpose of Laxatab (Sodium Picosulfate) is assisting with bowel movement facilitation, and it is commonly used to help with managing acute and chronic constipation symptoms. This medication is generally used for cleansing the colon as a preparation for medical procedures, but it also applies across therapeutic domains where additional symptomatic support is needed.

This agent is generally used to help with symptom clusters that may become intense or disruptive, such as hard stools, straining, and the subjective feeling of incomplete evacuation. The medication is relevant for easing challenging symptoms in situations involving: acute episodes, chronic functional constipation, preparation for surgical procedures or colonoscopy, and support in patients with ano-rectal conditions.

“It is commonly used across conditions presenting with acute episodes, and may help ease the impact of symptoms on routine activities.”

This provides support that may help ease the overall symptom burden, contributing to improved comfort during symptomatic periods. It is considered relevant for use in older individuals, bed-ridden patients, and children managing functional constipation.


Quick Fact: Symptomatic Support

Property Description
Primary Use Symptomatic support for constipation
Symptom Focus Hard stools and straining during defecation
Type of Support Provides supportive relief for difficult elimination
Clinical Scenario Bowel preparation before diagnostic procedures

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Laxatab (Sodium Picosulfate)

Official regulatory documents define strict criteria for using Laxatab based on pre-existing conditions and age. The medicine is contraindicated and must not be used in specific populations to prevent serious complications.


Absolute Contraindications

Condition
Severe Renal Impairment (Creatinine Clearance < 30 mL/minute)
Gastrointestinal (GI) Obstruction or Ileus
Bowel Perforation or Gastric Retention
Toxic Colitis, Toxic Megacolon, or Acute Abdominal Surgical Conditions
Severe Dehydration
Known Hypersensitivity to Sodium Picosulfate or its components

Eligibility and Age Restrictions

Population Eligibility Status (Regulatory Basis)
Adults Established for standard use.
Pediatric Use Established for children 9 or 10 years of age and older, depending on the specific formulation.
Children Under Threshold Use is Not Established or Not Recommended in children below the defined age thresholds.
Pregnancy/Lactation Use is conditional and requires caution, particularly during the first trimester of pregnancy. Should only be used if clearly needed or clearly indicated.

Conditional Use: Patients with mild to moderate renal impairment, a history of seizures, or those at risk of cardiac arrhythmias require caution. Fluid and electrolyte abnormalities must be corrected before treatment is initiated.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Laxatab (Sodium Picosulfate) by focusing on the effect of accelerated gastrointestinal transit and the drug's requirement for metabolic activation.

Documented Pharmacodynamic and Pharmacokinetic Interactions

Interaction Type Interacting Substances/Categories
Reduced Efficacy Oral Antibiotics (e.g., Tetracycline, Fluoroquinolone)
Reduced Absorption All Oral Medications, especially Digoxin, Iron, Penicillamine, Chlorpromazine
Additive Risk Drugs that affect fluid and electrolyte balance (e.g., Diuretics, Corticosteroids)

Co-administration with oral antibiotics may reduce the efficacy of Sodium Picosulfate because the drug requires specific bacterial flora in the colon for conversion into its active form. A major pharmacodynamic concern is the additive risk of fluid and electrolyte abnormalities, such as hypokalemia, when used concomitantly with diuretics or corticosteroids. Use with medicines that lower the seizure threshold may also increase the risk of seizure events due to potential electrolyte disturbances.

Administration Restrictions and Timing

To prevent the inadequate absorption of other drugs, official labels require timing separation. All oral medications should not be taken within one hour of the start of each Sodium Picosulfate dose. Specific sensitive oral medications, including Digoxin and Iron, require a more restrictive separation window, typically at least two hours before and six hours after administration. Co-administration with other laxatives is generally restricted. Concomitant use with alcohol is documented to increase the potential for side effects such as dizziness. Specific caution is noted for patients with impaired renal function due to increased risk of renal injury and electrolyte disturbances.

Mechanism of Action

Laxatab contains Sodium Picosulfate, a prodrug that becomes pharmacologically active upon cleavage by colonic bacteria. This active compound exerts a dual mechanism by interacting with both the enteric nervous system and the intestinal mucosa, modulating local motor and secretory functions.

Modulation of Enteric Nerve Plexus Activity

The active metabolite engages the myenteric plexus (Auerbach's plexus), the principal network of nerves controlling smooth muscle function in the large intestine. This interaction initiates signaling sequences that modulate the frequency and amplitude of peristaltic contractions within the colon.

Regulation of Colonic Fluid Transport

This domain involves altered transcellular and paracellular transport of water and electrolytes across the mucosal lining. The active metabolite acts directly on the intestinal wall to inhibit water and electrolyte absorption from the lumen while simultaneously promoting their secretion into the colon. This modification drives net fluid secretion, resulting in a measurable increase in luminal volume.

Dosage and Administration Information

Administration Route and Dosing Regimens

Laxatab (Sodium Picosulfate) is administered exclusively via the oral route in several official dosage forms, including tablets, oral solution, and a powder for reconstitution. The established protocol for use is divided into two principal categories.

1. Short-Term Constipation Relief

For short-term use, the standard adult regimen is a dose of 5 mg to 10 mg taken once daily. Administration is typically recommended at bedtime to align the 6- to 12-hour onset of action with morning evacuation. Continuous daily use for this purpose is restricted to not more than five days.


2. Bowel Cleansing for Procedures

When used as a procedural preparation (often as a combination product), the regimen requires two separate doses, each containing 10 mg Sodium Picosulfate. The typical regimen is a Split-Dose schedule, with the first dose taken the evening before and the second dose the morning of the procedure.

  • Preparation: If using the powder formulation, the powder must be dissolved in cold water (e.g., 5 ounces) immediately before ingestion; direct consumption of the powder is restricted.
  • Fluid Consumption: Mandatory consumption of clear liquids is required following each dose to ensure adequate hydration throughout the preparation course. Oral medications should be separated from the administration of the laxative dose by at least one hour.

Age-Specific Use

The single-agent form for constipation is approved for use in children aged 10 years and older. The combination product for bowel cleansing is approved for pediatric patients aged 9 years and older, following the two-dose adult regimen.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Laxatab

Evidence for Use in Chronic Functional Constipation

The primary evidence used in research exploring how symptoms change over time in chronic functional constipation comes from short-term, placebo-controlled clinical trials and Systematic Reviews that compile data from these trials. Research examined key outcomes related to physical discomfort, including bowel movement frequency (CSBMs) and objective measures of stool consistency. Studies report how symptoms were measured in the observed populations during the short treatment period, describing patterns observed in CSBM frequency and stool consistency measurements. A key limitation is that most high-quality trials were designed with follow-up durations limited to approximately four weeks, meaning there is limited information for long-term outcomes.


Evidence for Use in Acute Constipation

Laxatab was studied for its potential role in conditions associated with acute or disruptive episodes. Research relies primarily on Randomized Controlled Trials (RCTs) designed to monitor outcomes over very brief time intervals. These studies monitored key outcomes such as the time to the first spontaneous bowel movement (SBM) and the rate of achieving a pre-defined measure of symptom change. Findings describe patterns observed in the rapid onset of bowel movements, typically within 24 to 72 hours. However, the evidence is often contextualized within the population of chronic patients, and specific data for temporary, situational acute episodes in other groups remains limited.


Evidence for Use in Bowel Cleansing and Procedural Preparation

Laxatab was studied for its use in research contexts involving diagnostic preparations, such as colonoscopy. Research examined Comparative Clinical Studies and RCTs, frequently involving the medicine as a component of a combination product with osmotic agents. These studies monitored outcomes linked to preparation, focusing on cleansing scale scores as assessed by procedure examiners and the preparation rate attainment. A significant limitation is that most high-level studies use the medicine in a fixed-dose combination product, which makes it challenging to isolate the specific contributions of the Sodium Picosulfate component alone in this context.


What Research Gaps and Uncertainty Remain

Evidence quality varies across studies when examining certain special populations like children and the elderly, and data for these groups remain insufficient for definitive conclusions. Furthermore, long-term effects are not fully established, and the available studies provide limited definitive insight into the durability of the effect when the medicine is used continuously for periods beyond 12 months.

Key Studies & References

  1. Sodium Picosulfate Ferring 10mg Tablets - Summary of Product Characteristics (EMA/HPRA data)

Frequently Asked Questions (FAQ)

Common questions about Laxatab (FAQ)

Q: Does Laxatab help with chronic constipation or just temporary relief?

A: Official product information states that Laxatab (Sodium Picosulfate) is indicated for the short-term relief of functional constipation. It is also used as part of a regimen for bowel cleansing prior to medical procedures.

Q: Is Laxatab the same as bisacodyl, or is it a different type of drug?

A: Laxatab’s active ingredient is Sodium Picosulfate. While both Sodium Picosulfate and Bisacodyl are categorized as stimulant laxatives, they are generally considered to be distinct chemical compounds. According to official classification, they belong to the same pharmacological class of drugs.

Q: Can you become dependent on Laxatab if you use it regularly?

A: Official warnings state that prolonged use of Laxatab may lead to dependence on laxatives for normal bowel function. Due to this risk, regulatory documents advise that continuous use should be limited to short-term periods.

Q: Is Laxatab safe for older adults or the elderly?

A: Caution is generally advised when Laxatab is used in the elderly, as this population is at an increased risk of fluid and electrolyte imbalances. Regulatory warnings emphasize the importance of maintaining adequate fluid intake when this medication is used by older adults.

Q: Are there any known interactions between Laxatab and supplements like magnesium?

A: Official safety data indicates that Laxatab itself may cause increased magnesium levels in the blood (hypermagnesemia). Products or supplements that also affect electrolyte balance, such as magnesium, may require careful use due to this potential additive effect.

Q: Why is it important to stay hydrated when taking Laxatab?

A: It is important to maintain adequate hydration while using Laxatab. The medicine works by moving water and electrolytes into the colon, which can cause a significant loss of body water and potentially lead to dehydration and low blood volume (hypovolemia).

Q: Can Laxatab cause diarrhea or loose stools?

A: Yes, diarrhea and loose stools are commonly documented and expected adverse reactions. The medicine works as a strong purgative, and its mechanism of action is designed to induce comprehensive bowel evacuation, which can result in loose or watery stools.

Q: Is Laxatab recommended for use during pregnancy (as a general question)?

A: Laxatab is generally contraindicated or not recommended for use during pregnancy, especially during the first trimester. Regulatory documents warn that there is potential for serious harm to the unborn baby.

Q: What should I do if I forget to take a scheduled dose of Laxatab?

A: According to official patient information, if a dose is missed, individuals should wait until the next scheduled dose and should avoid taking the missed dose or doubling up doses.

Q: Can Laxatab affect the absorption of other medications?

A: Yes, Laxatab may interfere with the absorption of other orally administered medicines. This happens because the laxative speeds up the rate at which substances pass through the gastrointestinal tract.

Q: Is it normal to feel slightly bloated after taking Laxatab?

A: While the official side effect list reports abdominal discomfort, pain, and cramping, mild bloating may be experienced, as is sometimes the case with stimulant laxatives that increase fluid and gas movement in the bowel.

Q: For how long is it generally considered safe to use Laxatab?

A: Laxatab is restricted to short-term use to prevent the risk of dependency. Official regulatory guidelines generally state that use should not exceed one week (or five days for certain uses).

Q: Does taking Laxatab require any special diet changes?

A: When using Laxatab, especially for bowel cleansing, the consumption of clear liquids is often a mandatory part of the regimen to ensure adequate hydration. For general constipation relief, dietary advice often focuses on the mandatory fluid intake.

Q: Do antacids interfere with how well Laxatab works?

A: Regulatory information indicates that oral medications, which includes antacids, should be separated from the Laxatab dose. Taking them too close together may result in the reduced efficacy of the laxative.

Q: Can you take Laxatab with antibiotics?

A: Co-administration with oral antibiotics may potentially reduce the efficacy of Laxatab. This is because the laxative requires specific colon bacteria to convert it into its active form, and antibiotics can disrupt this process.

Q: What should be done if an overdose of Laxatab is suspected?

A: A suspected overdose may lead to severe symptoms, including excessive diarrhea, severe abdominal cramps, and significant electrolyte loss. Official information indicates that a suspected overdose warrants seeking immediate medical attention (such as from an emergency service or poison control center).

Q: Are there any documented cases of allergic reactions to Laxatab?

A: Yes, official safety data lists hypersensitivity to the drug or its components as a contraindication. Allergic reactions, including serious events like anaphylaxis and skin rash, have been reported in post-marketing experience.

Q: Does the time of day I take Laxatab matter?

A: Yes, for short-term constipation relief, administration is typically recommended at bedtime. This timing is suggested because the drug's onset of action (6 to 12 hours) will align with a desired morning bowel evacuation.

Q: Are headaches a possible side effect of Laxatab?

A: Yes, headache is listed as one of the commonly reported adverse reactions in official product documentation.

Q: Does Laxatab have a taste or odor?

A: Official product documents describe the oral solution and powder forms, particularly in combination products, as having a specific flavor and odor (e.g., being fruit-flavored).

Q: Is it normal to feel a cramping sensation just before Laxatab works?

A: Abdominal cramps and pain are commonly documented adverse reactions associated with the use of this medication. These sensations are commonly experienced and may be associated with the drug's mechanism of stimulating the colon.

Q: What are the signs that Laxatab is working effectively?

A: In clinical studies, effectiveness is measured by observed outcomes such as an increase in bowel movement frequency and a faster time to the first spontaneous bowel movement (SBM). In personal use, these measures provide an indication of the medicine's effectiveness.

Q: Can people with kidney problems safely use Laxatab?

A: The drug’s official classification includes a contraindication for severe renal impairment (a high level of kidney damage). Caution is advised for those with milder kidney problems due to the increased risk of electrolyte imbalance.

How should Laxatab be stored and disposed of?

Official Storage and Handling Requirements

Laxatab (Sodium Picosulfate) must be stored at Controlled Room Temperature, specifically 25 C (77 F), with permitted temperature excursions between 15 C and 30 C (59 F and 86 F). The product requires protection from both excessive humidity and light to maintain its stability.

To ensure safety, the medicine must be kept out of reach of children. The product should not be used if the outer packaging is opened or if the blister shows evidence of tampering, such as being torn or broken. Do not use the medicine past the expiration date.

Disposal Instructions

Unused or expired Laxatab must be discarded according to local regulations. Follow guidelines established by your national or local authority for pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Laxatab found in:

A-Z Index: